1. Home
  2. DBRG vs ICUI Comparison

DBRG vs ICUI Comparison

Compare DBRG & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DigitalBridge Group Inc.

DBRG

DigitalBridge Group Inc.

HOLD

Current Price

$15.70

Market Cap

2.9B

Sector

Real Estate

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$133.82

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DBRG
ICUI
Founded
1991
1984
Country
United States
United States
Employees
311
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.3B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
DBRG
ICUI
Price
$15.70
$133.82
Analyst Decision
Hold
Strong Buy
Analyst Count
8
3
Target Price
$16.00
$169.00
AVG Volume (30 Days)
2.7M
250.1K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
0.26%
N/A
EPS Growth
N/A
100.62
EPS
N/A
1.20
Revenue
N/A
$2,231,262,000.00
Revenue This Year
$373.39
N/A
Revenue Next Year
$8.23
$4.46
P/E Ratio
$252.25
$110.98
Revenue Growth
N/A
N/A
52 Week Low
$8.94
$107.02
52 Week High
$15.72
$160.29

Technical Indicators

Market Signals
Indicator
DBRG
ICUI
Relative Strength Index (RSI) 71.54 63.35
Support Level $15.33 $131.99
Resistance Level N/A $153.00
Average True Range (ATR) 0.03 5.06
MACD 0.00 1.56
Stochastic Oscillator 91.18 97.00

Price Performance

Historical Comparison
DBRG
ICUI

About DBRG DigitalBridge Group Inc.

DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centres, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: